Posts for Ticker ‘CNH’

52-Week High Club

Autodesk Inc. (NASDAQ: ADSK) rallied over 5% to a yearly high of $27.26 after the company’s shares were upgraded to “buy” by Kaufman Brothers LP, who set their 12 month price target at $30.

Genex Corporation (NASDAQ: GNTX) jumped over 20% today after the vehicle mirror supplier announced a 3Q profit of $0.17, beating analyst estimates.

CNH Global NV (NYSE: CNH) jumped over 12% to a yearly high of $22.75 after the tractor maker reported a loss of $0.09 per share, beating analyst estimates. 

Morgan Stanley (NYSE: MS) rallied over 5% to a yearly high of $35.00 after the company reported a 3Q profit of $0.38 per share and declared a dividend of $.05.

Garrett W. McIntyre

Top Pre-Market Analyst Downgrades (BAC, BBBY, BHP, C, CNH, LECO, SNY, USB)

Burning_money_picThese are some of the top pre-market analyst downgrades and negative calls from Wall Street we have seen early this Monday morning with more than two and a half hours to the market open:

  • Bank of America (BAC) Cut to Neutral at Goldman Sachs.
  • Bed Bath & Beyond (BBBY) Cut to Underweight at JPMorgan.
  • BHP Billiton (BHP) Cut to Hold at Citigroup.
  • Citigroup (C) remains a Sell at Goldman Sachs.
  • CNH Global (CNH) Cut to Underweight at JPMorgan.
  • Lincoln Electric (LECO) Cut to Sell at Piper Jaffray.
  • Sanofi-Aventis (SNY) Started As Underperform at at Jefferies.
  • USBancorp (USB) Cut to Sell at Goldman Sachs.

Jon C. Ogg
January 26, 2009

Top 10 Pre-Market Analyst Calls (AG, HBC, CNH, MEOH, OMTR, PLD, RYAAY, SLM, PCU, VE)

These are the top 10 analyst calls that we are focusing on this Tuesday morning:

  • AGCO Corp. (NYSE: AG) raised to Overweight at Goldman Sachs.
  • HSBC Holdings (NYSE: HBC) cut to Neutral at UBS
  • CNH Global NV (NYSE: CNH) cut to Neutral at Goldman Sachs.
  • Methanex (NASDAQ: MEOH) raised to Buy at UBS.
  • Omniture (NASDAQ: OMTR) raised to Buy at Piper Jaffray.
  • ProLogis (NYSE: PLD) cut to Outperform from Top Pick at    RBC Capital Markets.
  • Ryanair (NASDAQ: RYAAY) cut to Sell from Hold at Deutsche Bank.
  • SLM Corp (NYSE: SLM) raised to Overweight at Lehman Brothers.
  • Southern Copper (NYSE: PCU) cut to Neutral at HSBC Securities.
  • Veolia Environnement (NYSE: VE) Cut To Neutral By JPMorgan.

Jon C, Ogg
May 6, 2008

Goldman Sachs Conviction Buy List Changes (CI, WLP, CNH)

Goldman Sachs is making a change to its CONVICTION BUY LIST this morning.  The firm is adding CIGNA (NYSE: CI) and dropping WellPoint (NYSE: NYSE: WLP) from the list.  Both stocks are still maintained as officially being BUY rated there, but Goldman Sachs sees a near-term opportunity in CIGNA shares.  In fact, the 6-month price target on CIGNA gives an implied upside of 30%.

CNH Global N.V. has also been booted off of the CONVICTION BUY LIST, although that is because of a stop-loss feature.  The firm is maintaining a BUY rating and says it is not a seller at current levels.  The stock is down some 22% since its addition to the list on November 27, 2007.

Jon C. Ogg
February 8, 2008

Pre-Market Stock News (January 23, 2008)

We are full fledged into earnings season now, so most news coverage will point to the current earnings environment and guidance.  There are of course drug developments and other contracts awards.  Below is a snapshot of some of the key data we saw affecting shares in pre-market trading:

  • Abbott Laboratories (ABT) $0.93 EPS versus $0.92 estimate; sees Q1 EPS $0.61 to $0.63 versus $0.65 estimates and sees 2008 EPS $3.20 to $3.25 versus $3.22 estimate.
  • Advanced Energy Industries Inc. (NASDAQ: AEIS) traded down over 10% after after it lowered guidance.
  • Air Products (APD) $1.16 EPS vs $1.13 estimates. 
  • Apple Inc. (AAPL) trading down 10% after it posted $1.76 EPS on $9.6 Billion revenues; Estimates were $1.62 EPS on revenues of $9.47 Billion; Guidance for next quarter is $0.94 EPS and revenues $6.8 Billion versus estimates of $1.09 EPS on $6.98 Billion in revenues.
  • Baidu.com (BIDU) announces the formal launch of its Japanese language search engine run by its Japanese subsidiary.
  • CheckPoint Software (CHKP) trading up almost 5% after $0.46 EPS versus $0.45 est.; Revenues $206.7M vs. $202.3M est.;
  • CNH Global (CNH) $0.50 EPS versus $0.60 estimate.
  • Coach (COH) $0.69 EPS vs $0.68 estimate; noted weak mall traffic and decline in average transaction size.
  • EntreMed (ENMD) is starting its Phase II study with its MKC-1 cell cycle inhibitor in ovarian cancer and advanced endometrial cancer.
  • Ethan Allen (ETH) posted $0.70 EPS versus $0.68 estimate.
  • Foster Wheeler (FWLT) trades ex-split to reflect a 2 for 1 stock split.
  • General Dynamics (GD) $1.42 EPS vs. $1.41 estimate; sees 2008 EPS $5.55 to $5.65 versus $5.73 estimate.
  • HOKU Scientific Inc. (HOKU) traded down 10% after earnings beat but guidance was deemed light.
  • INX (INXI) awarded Department of Defense contract to provide up to $21 million in support  of a Cisco Systems network pact.
  • Martek Biosciences (MATK) noted a December publication showed its DHA may help in late-onset Alzheimer’s, although NIH study results will be in 2010.
  • Parametric (PMTC) $0.26 EPS vs. $0.23 estimate; sees next quarter $0.24 to $0.28 vs. $0.26 estimate; sees 2008 EPS $1.17 to $1.27 vs. $1.16 estimate (revenue in-line).
  • Praxair (PX) $0.98 EPS vs $0.97 estimate.
  • Qualcomm (QCOM) expanded relationship with Motorola for chipsets into certain UMTS 3G handsets in 2008 and 2009.
  • RLI Corp. (RLI) $1.22 EPS versus $1.05 estimate.
  • Rockwell Automation (ROK) $1.04 EPS vs. $1.01 estimates; guides 200 EPS $4.25 to $4.45 versus $4.38 estimate.
  • Southwest Airlines (LUV) $0.12 EPS vs. $0.10 estimate ; reigned in 2008 growth plans to 4%-5% capacity.
  • Texas Instruments Inc. (TXN) has posted earnings of $0.54 EPS and revenues of $3.56 Billion; analysts pegged at $0.52 EPS on $3.58 Billion in revenues; sees Next quarter $0.43 to $0.49 EPS on revenues of $3.27 to $3.55 Billion versus estimates of $0.45 EPS on $3.41 Billion in revenues.
  • TJX Companies (TJX) was Jim Cramer’s retail pick on CNBC’s MAD MONEY last night.
  • United Tech (UTX) $1.08 EPS vs. $1.06 estimate; sees 2008 $4.65 to $4.85 versus $4.85 estimate.
  • Vertex Pharmaceuticals (VRTX) will begin Phase III evaluation of telaprevir for its lead investigational hepatitis C protease inhibitor.
  • WellPoint (WLP) $1.51 EPS versus $1.51 estimate.
  • Werner Enterprises (WERN) $0.28 EPS vs. $0.28 estimate.

Jon C. Ogg
January 23, 2008